Ralf-Dieter Hofheinz (R Hofheinz, Ralf Hofheinz, R-D Hofheinz)
ORCIDPublication Activity (10 Years)
Years Active: 2016-2023
Publications (10 Years): 10
Publications (10 Years): 10
Publications
- Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience, Matthias Biebl, Nils Homann, Michael Schenk, Udo Lindig, Vera Heuer, Albrecht Kretzschmar, Eray Goekkurt, Georg Martin Haag, Jorge Riera-Knorrenschild, Claus Bolling, Ralf-Dieter Hofheinz, Tianzuo Zhan, Stefan Angermeier, Thomas Jens Ettrich, Alexander Reinhard Siebenhüner, Moustafa Elshafei, Wolf Otto Bechstein, Timo Gaiser, Maria Loose, Disorn Sookthai, Christina Kopp, Claudia Pauligk, Salah-Eddin Al-Batran, null nullPerioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
- Ralf-Dieter Hofheinz, Sylvie Lorenzen, Michael K Bohlmann
- Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Hans G Kopp, Daniel Pink, Gabriele Siegler, Michael Schenk, Ferdinando De Vita, Gennaro Galizia, Evaristo Maiello, Wolf O Bechstein, Moustafa Elshafei, Maria Loose, Disorn Sookthai, Tanita Brulin, Claudia Pauligk, Nils Homann, Salah-Eddin Al-Batran
- Anna Lena Hohneck, Largsi Sadikaj, Lara Heinemann, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried, Ralf-Dieter Hofheinz
- Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, Christoph Springfeld, Thomas Jens Ettrich, Kersten Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Siegler, Matthias P Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf Bechstein, Peter Reichardt, Hagen Flach, Timo Gaiser, Achim Battmann, Fuat S Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten O Göetze, Salah-Eddin Al-BatranFLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
- Ralf-Dieter Hofheinz, Susanne Hegewisch-Becker, Volker Kunzmann, Peter Thuss-Patience, Martin Fuchs, Nils Homann, Ullrich Graeven, Nadine Schulte, Kirsten Merx, Michael Pohl, Swantje Held, Ralph Keller, Andrea Tannapfel, Salah-Eddin Al-BatranTrastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group. International journal of cancer 149 (6) (2021)
- Harald Matthes, Anja Thronicke, Ralf-Dieter Hofheinz, Erik Baars, David D Martin, Roman Huber, Thomas Breitkreuz, Gil Bar-Sela, Daniel Galun, Friedemann Schad
- U I Attenberger, J Winter, Felix N Harder, I Burkholder, D Dinter, S Kaltschmidt, P Kienle, S O Schoenberg, Ralf-Dieter Hofheinz
- Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, Timo Gaiser, Sebastian Eidt, Juliana Schwaab, Stefan Post, Frederik Wenz, Andreas Hochhaus, Ralf-Dieter Hofheinz, Philipp Erben
- Ralf-Dieter Hofheinz, Ulrich Ronellenfitsch, S Kubicka, A Falcone, I Burkholder, U T Hacker